Nippon Shinyaku (4516) · InitiativeChange in the stated term of the agreement
Agreement for the transfer of marketing authorization for tadalafil products
First written in FY2020-Q1. 1 of 3 entries say "Restated". Latest entry: FY2026.
3entries
8years
0from disclosures
How it moved
Same theme, other companies
Agreement for the transfer of marketing authorization for tadalafil productsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2026Change in the stated term of the agreementAnnual report
「Agreement concerning the transfer of marketing authorization for tadalafil products in Japan, through 14 February 2032」
The stated term of the agreement for the transfer of marketing authorization for tadalafil products has changed from December 2031 to 14 February 2032. - FY2021RestatedAnnual report
「Agreement concerning the transfer of marketing authorization for tadalafil products in Japan」
The agreement for the transfer of marketing authorization for tadalafil products has been reiterated as a material business agreement. - FY2020-Q1First statedAnnual report
「Agreement concerning the transfer of marketing authorization for tadalafil products in Japan」
In May 2019, the company entered into an agreement with Eli Lilly and Company and Eli Lilly Japan K.K., with the term stated as running through December 2031.